As per Fact.MR – a market research and competitive intelligence provider, the global canine anxiety separation treatment market was valued at US$ 21.4 Mn in 2020, and is expected to exhibit a CAGR of around 6% during the forecast period (2021-2031).
Canines, like human beings, experience anxiety issues. Dog anxiety can affect all breeds; however, it might differ from one dog to another. Separation anxiety is commonly observed in dogs who are overly attached to their owners, and it is estimated to affect around 14% of dogs, globally.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1490
Canines suffering from anxiety often exhibit undesirable behavior such improper urinating and defecation, excessive salivation, and destroying furnishing and exit points such as windows and doors. If ignored or left untreated, it can have a long-term impact on the dog’s mental health. Factors such as these will create demand for better treatment options for separation anxiety disorders in dogs. Also, growing adoption of canines and increasing spend on animal health are anticipated to have a positive impact on market growth.
Key Takeaways from Market Study
By drug molecule, clomipramine to hold around 50% value share, globally, primarily owing to its higher effectiveness and well-tolerance in controlling separation anxiety as compared to other drugs.Based on anxiety type, aggressive anxiety is leading with 60% market share, owing to growing destructive behavior among canines.Veterinary clinics widely dominate at 36% market share, owing to growing number veterinary practices and significant prevalence of canine anxiety across various region.By region, North America is expected to dominate the global canine separation anxiety market with a value share of 32% through the forecast period. Europe is the second-largest market with a value share of 21%.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1490
Key Market Segments Covered in Canine Separation Anxiety Treatment Industry Research
By Drug Molecule
Alprazolam (XanaX) Canine Separation Anxiety TreatmentAmitriptyline Canine Separation Anxiety TreatmentBuspirone Canine Separation Anxiety TreatmentClomipramine Canine Separation Anxiety TreatmentDexmedetomidine Canine Separation Anxiety TreatmentDiazepam (Valium) Canine Separation Anxiety TreatmentFluoxetine Hydrochloride Canine Separation Anxiety TreatmentOthers
By Anxiety Type
Aggressive Canine Separation Anxiety TreatmentNon-Aggressive Canine Separation Anxiety Treatment
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/1490
Strategy by Market Players
Collaborations and acquisitions were identified as the preferred key growth strategies adopted by leading players in this market. By pursuing these strategies, it helps them expand their geographic footprint and strengthen their existing product portfolio.
An example is the recent acquisition of Bayer Animal Division by Elanco Animal Health, Inc., in August 2020. This acquisition enabled Elanco to expand its current product offerings and strengthen its foothold in the global animal health industry. Also, Elanco’s long-standing focus on veterinarians is combined with Bayer Animal Health’s direct-to-consumer expertise to create new opportunities for growth.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/31/2009232/0/en/Fact-MR-Forecasts-Sales-of-Audiological-Devices-to-Exceed-US-13-Bn-by-2026-Receiver-in-the-ear-Will-Remain-Bestselling-Reveals-a-New-Report.html
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
